Search results
Why Nektar Therapeutics Stock Is Plunging Today
Benzinga via Yahoo Finance· 1 year agoNektar Therapeutics (NASDAQ: NKTR) announced topline data from a Phase 2 study of rezpegaldesleukin (LY3471851 or REZPEG) in adults with...
Nektar (NKTR) Stock Surges 75% in a Week: Here's Why
Zacks via Yahoo Finance· 9 months agoNektar’s NKTR shares soared as the company announced new and promising corrected data from studies on its lead pipeline candidate rezpeg. According to...
Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
Zacks via Yahoo Finance· 9 months agoNektar Therapeutics NKTR reported a loss of 27 cents per share for the second quarter of 2023, which...
Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss
Zacks via Yahoo Finance· 6 months agoNektar Therapeutics NKTR reported an adjusted loss of 19 cents per share for the third quarter of...
Nektar (NKTR) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 1 year agoInvestors might want to bet on Nektar Therapeutics (NKTR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a...
Nektar's (NKTR) Q1 Earnings Top, Workforce Reduction on Track
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) reports encouraging first-quarter 2022 results. The company remains on track with its...
Nektar Therapeutics (NKTR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings...
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased...
Nektar Therapeutics (NKTR) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNektar (NKTR) delivered earnings and revenue surprises of 31.94% and 3.22%, respectively, for the...
Nektar (NKTR) Starts New Restructuring Plan to Curb Cash Burn
Zacks via Yahoo Finance· 1 year agoThe new restructuring plan will allow Nektar (NKTR) to extend its cash runway into mid-2026. The...